Back
Keros Therapeutics, Inc. Vs. Syndax Pharmaceuticals, Inc. Industry Stock Comparison
Buy
58
KROS
Keros Therapeutics, Inc.
Last Price:
$20.84
Seasonality Move:
4.91%
Sell
41
SNDX
Syndax Pharmaceuticals, Inc.
Last Price:
$21.29
Seasonality Move:
13.43%
Buy
58
Keros Therapeutics, Inc. (KROS)
is a Buy
Is Keros Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Keros Therapeutics, Inc. [KROS] share price is $21.03. The Score for KROS is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
-
KROS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
41
Syndax Pharmaceuticals, Inc. (SNDX)
is a Sell
Is Syndax Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Syndax Pharmaceuticals, Inc. [SNDX] share price is $21.30. The Score for SNDX is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
SNDX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
KROS Stock Price Chart
What is Keros Therapeutics, Inc.'s stock price today?
-
The Keros Therapeutics, Inc. share price today is $21.03The current trend is moderately bullish and KROS is experiencing selling pressure, which indicates risk of future bearish movement.
SNDX Stock Price Chart
What is Syndax Pharmaceuticals, Inc.'s stock price today?
-
The Syndax Pharmaceuticals, Inc. share price today is $21.30Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SNDX is experiencing slight selling pressure.
KROS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.98 | Buy |
| Relative Strength Index (14 RSI): | 61.24 | Buy |
| Chaikin Money Flow: | -183368 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.85 - 21.71) | Buy |
| Bollinger Bands (100): | (14.28 - 18.78) | Buy |
SNDX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.82 | Buy |
| Relative Strength Index (14 RSI): | 64.52 | Buy |
| Chaikin Money Flow: | -274595 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (18.94 - 21.14) | Buy |
| Bollinger Bands (100): | (14.12 - 18.84) | Buy |
KROS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 20.98 | Buy |
| 20-day SMA: | 20.43 | Buy |
| 50-day SMA: | 17.81 | Buy |
| 200-day SMA: | 14.95 | Buy |
| 8-day EMA: | 21.04 | Sell |
| 20-day EMA: | 20.3 | Buy |
| 50-day EMA: | 18.58 | Buy |
| 200-day EMA: | 18.77 | Buy |
SNDX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.02 | Buy |
| 20-day SMA: | 20.37 | Buy |
| 50-day SMA: | 17.6 | Buy |
| 200-day SMA: | 13.73 | Buy |
| 8-day EMA: | 17.6 | Buy |
| 20-day EMA: | 10.65 | Buy |
| 50-day EMA: | 5.15 | Buy |
| 200-day EMA: | 1.42 | Buy |
Keros Therapeutics, Inc. Earnings Growth & KROS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.62 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.45 per share, and a decrease next year of $5.27 per share.
Syndax Pharmaceuticals, Inc. Earnings Growth & SNDX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.38 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.25 per share, and an increase next year of $1.31 per share.
Keros Therapeutics, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Syndax Pharmaceuticals, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||